APA (7th ed.) Citation

SK, P., G, S., J, M., V, N., X, W., A, Z., . . . CV, C. (2021). Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma. Cancers, 13(23), . https://doi.org/10.3390/cancers13236029

Chicago Style (17th ed.) Citation

SK, Pandit, et al. "Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma." Cancers 13, no. 23 (2021). https://doi.org/10.3390/cancers13236029.

MLA (9th ed.) Citation

SK, Pandit, et al. "Mitochondrial Plasticity Promotes Resistance to Sorafenib and Vulnerability to STAT3 Inhibition in Human Hepatocellular Carcinoma." Cancers, vol. 13, no. 23, 2021, https://doi.org/10.3390/cancers13236029.